New approach to testing treatments for osteoarthritis: FastOA.
David T FelsonMartin K LotzYuxuan JinMorgan JonesJason S KimKurt SpindlerPublished in: Annals of the rheumatic diseases (2023)
Animal models of post traumatic osteoarthritis have shown many promising treatments for disease, but human trials have mostly failed to identify effective treatments. This viewpoint suggests that the frequent failure of drug and treatment development in osteoarthritis is due, in part, to the advanced stage of disease of patients in trials and suggests that mirroring the animal model approach might be more successful. It suggests a path forward by enriching trial enrollees with those likely to develop post traumatic OA quickly.
Keyphrases
- knee osteoarthritis
- rheumatoid arthritis
- end stage renal disease
- endothelial cells
- newly diagnosed
- ejection fraction
- chronic kidney disease
- clinical trial
- peritoneal dialysis
- prognostic factors
- randomized controlled trial
- study protocol
- emergency department
- induced pluripotent stem cells
- patient reported outcomes
- drug induced
- combination therapy
- replacement therapy